As we age, our vision undergoes natural changes, including difficulty focusing on near objects (presbyopia) and reduced light ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

Researchers have identified two molecules, agmatine and thiamine, that could enable early detection and potentially new treatments for the incurable eye disease, glaucoma.

Annual event accelerates progress toward curing glaucoma, from groundbreaking research to emerging therapiesSAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today ...

Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...

It's one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually ...

Synthetic cannabinoids and nicotinamide were among alternative treatment approaches discussed by Professor Augusto ...

Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred. Known as the “silent thief of sight,” the disease ...

BOZEMAN, MT – November 04, 2025 – PRESSADVANTAGE – Glaucoma continues to be one of the most significant causes of vision loss across the country, often developing slowly and without obvious warning ...

"OMNI continues to deliver results for patients, whether it be patients undergoing cataract surgery, those that have already had cataract surgery and are now pseudophakic, or groups at historically ...